Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial and viral lipid membranes are essential structural components that define the boundary of the pathogen and maintain its physiological integrity. In bacteria, the cytoplasmic membrane is responsible for critical processes including energy transduction via the proton motive force, lipid biosynthesis, and the selective transport of ions and nutrients (Sohlenkamp & Geiger, 2016, FEMS Microbiology Reviews). Enveloped viruses utilize a lipid bilayer, typically acquired from the host cell membrane during budding, which serves as a scaffold for viral glycoproteins necessary for host cell recognition and entry (Lorizate & Kräusslich, 2011, Cold Spring Harbor Perspectives in Biology). These membranes are distinct from mammalian membranes in their lipid composition, such as the high content of negatively charged lipids like phosphatidylglycerol in bacteria or the presence of an outer membrane containing lipopolysaccharides in Gram-negative species (Epand et al., 2016, Biochimica et Biophysica Acta). Therapeutic agents like polymyxins and daptomycin target these specific lipid environments to induce membrane permeabilization, depolarization, or physical disruption, leading to rapid loss of cellular homeostasis and pathogen death (Boparai & Sharma, 2020, Frontiers in Microbiology). While highly effective, targeting these structures presents challenges due to potential cross-reactivity with host cell membranes, which can result in significant toxicities such as nephrotoxicity or hemolysis (Falagas & Kasiakou, 2006, Critical Care).
Disruption of membrane integrity through pore formation, depolarization of the transmembrane potential, or inhibition of membrane fusion.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial and viral lipid membranes.